TTAB Oppositions 91247175

USPTO Oppositions proceeding 91247175, filed 2019-03-25. Status: Terminated.

Proceeding Facts

Proceeding Number	91247175
Type	Oppositions
Status	Terminated
Filing Date	2019-03-25
Last Activity	2023-05-22
Days Active	2608

Parties

Allogene Therapeutics, Inc. — Defendant
Atara Biotherapeutics, Inc. — Plaintiff

Plaintiff Marks

No plaintiffs on record.

Defendant Marks

ALLOCAR T — Allogene Therapeutics, Inc.

Recent Documents

2023-05-22: TERMINATED — Status
2023-03-06: FINAL DECISION: OPP SUSTAINED — Decisions
2022-11-07: SUBMITTED ON BRIEF ACR — Appeals
2022-08-11: D OPP/RESP TO MOTION — Motions
2022-07-28: RESPONSE DUE — Scheduling
2022-03-18: D OPP/RESP TO MOTION — Motions
2022-02-25: D REBUTTAL BRIEF: TM RULE 2.128 — Miscellaneous
2022-02-25: P REBUTTAL BRIEF: TM RULE 2.128 — Appeals
2022-02-07: D MAIN BRIEF: TM RULE 2.128 — Appeals
2022-02-07: P MAIN BRIEF: TM RULE 2.128 — Appeals
2022-02-04: STIP REGARDING ACR BRIEF LENGTH — Miscellaneous
2021-09-22: STIPULATED MOTION GRANTED TO USE ACR — Miscellaneous
2021-08-12: STIP TO ACCELERATED CASE RESOLUTION — Miscellaneous
2021-06-29: SUSP PEND DISP OF OUTSTNDNG MOT — Status
2021-06-01: P MOT FOR SUMMARY JGT DENIED — Decisions
2021-01-29: P REPLY IN SUPPORT OF MOTION — Motions
2021-01-11: D OPP/RESP TO MOTION — Motions
2021-01-11: D OPP/RESP TO MOTION — Motions
2020-12-21: SUSP PEND DISP OF OUTSTNDNG MOT — Status
2020-12-11: P MOT FOR SUMMARY JUDGMENT — Motions
2020-11-09: EXTENSION OF TIME GRANTED — Extensions
2020-09-28: D CHANGE OF CORRESP ADDRESS — Parties
2020-09-08: D NOTICE OF SERVICE OF REBUTTAL DISCLOSURE — Miscellaneous
2020-08-17: D MOT FOR EXT W/ CONSENT — Motions
2020-07-22: SUSPENDED — Status
2020-07-20: P OPP/RESP TO MOTION — Motions
2020-07-13: D MOT FOR EXT W/O CONSENT — Motions
2020-06-25: P NOTICE OF SERVICE OF EXPERT DISCLOSURE — Miscellaneous
2020-04-03: SUSPENDED — Status
2020-04-03: P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions

Related